Incyte Insider Trades
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 22 · $18.20M
- Shares bought / sold
- 0 / 152.72K
- Net activity
- Net selling $18.2 million
Incyte insider activity
Over the last 12 months, Incyte insiders reported 81 transactions on SEC Form 4: 0 open-market purchases and 22 sales. Insiders bought $0 and sold $18.2 million worth of stock, for net insider selling of $18.2 million. The largest seller was CAGNONI PABLO J, with $8.7 million in reported sales.
The most recent filing shows Heeson Lee (EVP, Head of Incyte Intl) reporting a transaction in 463 shares at $117.14 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INCY's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
INCY insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Heeson LeeEVP, Head of Incyte Intl | Tax withholding | 463 | $54.24K | Form 4 |
| Sep 30, 2026 | HARRIGAN EDMUNDDirector | Award | 206 | $25.00K | Form 4 |
| Sep 30, 2026 | Clancy Paul JDirector | Award | 203 | $24.63K | Form 4 |
| Sep 30, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 322 | — | Form 4 |
| Sep 30, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 322 | — | Form 4 |
| Sep 22, 2026 | Gardner David HEVP, Chief Strategy Officer | Tax withholding | 920 | $116.78K | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 13,985 | $1.69M | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 9,233 | $1.11M | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 9,233 | $664.13K | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 6,477 | $416.15K | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 4,551 | $278.43K | Form 4 |
| Sep 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 2,957 | $182.62K | Form 4 |
| Aug 25, 2026 | Basi Ramitpal KEVP, Human Resources | Tax withholding | 504 | $65.38K | Form 4 |
| Aug 19, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 10,801 | $1.36M | Form 4 |
| Aug 12, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 10,803 | $1.30M | Form 4 |
| Aug 5, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 2,207 | $273.65K | Form 4 |
| Aug 5, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,207 | $234.98K | Form 4 |
| Aug 5, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 10,640 | $1.31M | Form 4 |
| Aug 3, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 6,055 | $729.20K | Form 4 |
| Aug 3, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 6,055 | $638.38K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 2,293 | $273.81K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 326 | $39.67K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 85 | $10.39K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 1,642 | $196.02K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 1,643 | $196.35K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 2,864 | $341.96K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 4,695 | $560.54K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 6,171 | $737.00K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 2,187 | $261.28K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 5,332 | $636.75K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Sale | 14,661 | $1.75M | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 326 | $34.37K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 85 | $9.05K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,293 | $207.65K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 1,642 | $139.59K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,623 | $219.23K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 3,023 | $251.51K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 1,643 | $132.26K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,864 | $222.45K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,623 | $196.15K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 9,459 | $683.60K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,072 | $149.04K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 3,148 | $216.02K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,709 | $167.31K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,284 | $146.75K | Form 4 |
| Jul 31, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise | 2,918 | $178.52K | Form 4 |
| Jul 31, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sale | 15,888 | $1.90M | Form 4 |
| Jul 16, 2026 | Meury WilliamChief Executive Officer | Award | 26,807 | — | Form 4 |
| Jul 16, 2026 | Hoffman Richard A.EVP & General Counsel | Award | 7,395 | — | Form 4 |
| Jul 16, 2026 | Gardner David HEVP, Chief Strategy Officer | Award | 7,395 | — | Form 4 |
| Jul 16, 2026 | Basi Ramitpal KEVP, Human Resources | Award | 4,991 | — | Form 4 |
| Jul 16, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Award | 13,403 | — | Form 4 |
| Jul 16, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Award | 5,916 | — | Form 4 |
| Jul 16, 2026 | Issa Mohamed KhairieEVP, Head of U.S. Commercial | Award | 7,857 | — | Form 4 |
| Jul 16, 2026 | Issa Mohamed KhairieEVP, Head of U.S. Commercial | Sale | 1,093 | $125.71K | Form 4 |
| Jul 16, 2026 | Tray ThomasPrincipal Accounting Officer | Award | 2,834 | — | Form 4 |
| Jul 16, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Award | 9,798 | — | Form 4 |
| Jul 16, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Sale | 1,877 | $215.35K | Form 4 |
| Jul 15, 2026 | Issa Mohamed KhairieEVP, Head of U.S. Commercial | Tax withholding | 1,099 | $126.48K | Form 4 |
| Jul 15, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Tax withholding | 1,512 | $174.02K | Form 4 |
| Jul 15, 2026 | Tray ThomasPrincipal Accounting Officer | Tax withholding | 1,098 | $126.37K | Form 4 |
| Jul 15, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Tax withholding | 4,950 | $569.70K | Form 4 |
| Jul 15, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Tax withholding | 3,088 | $355.40K | Form 4 |
| Jul 15, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Sale | 28,237 | $3.19M | Form 4 |
| Jul 14, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Tax withholding | 437 | $50.20K | Form 4 |
| Jul 14, 2026 | Tray ThomasPrincipal Accounting Officer | Tax withholding | 692 | $79.50K | Form 4 |
| Jul 14, 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Tax withholding | 17,969 | $2.06M | Form 4 |
| Jul 14, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Tax withholding | 21,830 | $2.51M | Form 4 |
| Jul 2, 2026 | Stein Steven HCMO & Head of Late-Stage Dev. | Tax withholding | 2,177 | $254.40K | Form 4 |
| Jul 2, 2026 | Meury WilliamChief Executive Officer | Tax withholding | 4,779 | $558.47K | Form 4 |
| Jul 2, 2026 | Tray ThomasPrincipal Accounting Officer | Tax withholding | 477 | $55.74K | Form 4 |
| Jul 2, 2026 | Mayes Patrick AEVP & Chief Scientific Officer | Tax withholding | 350 | $40.90K | Form 4 |
| Jun 30, 2026 | HARRIGAN EDMUNDDirector | Award | 255 | $28.91K | Form 4 |
| Jun 30, 2026 | Clancy Paul JDirector | Award | 252 | $28.57K | Form 4 |
| Jun 30, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 400 | — | Form 4 |
| Jun 30, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 400 | — | Form 4 |
| Jun 8, 2026 | Clancy Paul JDirector | Award | 1,642 | — | Form 4 |
| Jun 8, 2026 | FOUSE JACQUALYN ADirector | Award | 1,642 | — | Form 4 |
| Jun 8, 2026 | HARRIGAN EDMUNDDirector | Award | 1,642 | — | Form 4 |
| Jun 8, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 1,642 | — | Form 4 |
| Jun 8, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 1,642 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4